Matches in Wikidata for { <http://www.wikidata.org/entity/Q86584617> ?p ?o ?g. }
- Q86584617 description "2015 nî lūn-bûn" @default.
- Q86584617 description "2015年の論文" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年学术文章" @default.
- Q86584617 description "2015年學術文章" @default.
- Q86584617 description "2015年學術文章" @default.
- Q86584617 description "2015年學術文章" @default.
- Q86584617 description "2015年學術文章" @default.
- Q86584617 description "2015年學術文章" @default.
- Q86584617 description "2015년 논문" @default.
- Q86584617 description "article científic" @default.
- Q86584617 description "article scientific" @default.
- Q86584617 description "article scientifique" @default.
- Q86584617 description "articol științific" @default.
- Q86584617 description "articolo scientifico" @default.
- Q86584617 description "artigo científico" @default.
- Q86584617 description "artigo científico" @default.
- Q86584617 description "artigo científico" @default.
- Q86584617 description "artikel ilmiah" @default.
- Q86584617 description "artikull shkencor" @default.
- Q86584617 description "artikulong pang-agham" @default.
- Q86584617 description "artykuł naukowy" @default.
- Q86584617 description "artículo científico publicado en 2015" @default.
- Q86584617 description "artículu científicu" @default.
- Q86584617 description "bilimsel makale" @default.
- Q86584617 description "bài báo khoa học" @default.
- Q86584617 description "im Februar 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86584617 description "naučni članak" @default.
- Q86584617 description "scienca artikolo" @default.
- Q86584617 description "scientific article published in February 2015" @default.
- Q86584617 description "scientific article published in February 2015" @default.
- Q86584617 description "scientific article published on 01 February 2015" @default.
- Q86584617 description "teaduslik artikkel" @default.
- Q86584617 description "tieteellinen artikkeli" @default.
- Q86584617 description "tudományos cikk" @default.
- Q86584617 description "vedecký článok" @default.
- Q86584617 description "vetenskaplig artikel" @default.
- Q86584617 description "videnskabelig artikel udgivet februar 2015" @default.
- Q86584617 description "vitenskapelig artikkel" @default.
- Q86584617 description "vitskapeleg artikkel" @default.
- Q86584617 description "vědecký článek" @default.
- Q86584617 description "wetenschappelijk artikel" @default.
- Q86584617 description "επιστημονικό άρθρο" @default.
- Q86584617 description "мақолаи илмӣ" @default.
- Q86584617 description "наукова стаття, опублікована в лютому 2015" @default.
- Q86584617 description "научна статия" @default.
- Q86584617 description "научная статья" @default.
- Q86584617 description "научни чланак" @default.
- Q86584617 description "научни чланак" @default.
- Q86584617 description "מאמר מדעי" @default.
- Q86584617 description "مقالة علمية نشرت في فبراير 2015" @default.
- Q86584617 description "ফেব্রুয়ারি ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q86584617 description "บทความทางวิทยาศาสตร์" @default.
- Q86584617 description "სამეცნიერო სტატია" @default.
- Q86584617 name "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 name "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 name "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 type Item @default.
- Q86584617 label "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 label "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 label "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 prefLabel "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 prefLabel "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 prefLabel "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 P1433 Q86584617-27BEC1FD-DC88-41F8-BD94-B09A2C64F9FE @default.
- Q86584617 P1476 Q86584617-268627D9-5C2E-40BA-AC2A-76B95E8EF7CC @default.
- Q86584617 P2093 Q86584617-3E509339-E951-48E0-BBAF-9C0AACAD984F @default.
- Q86584617 P2093 Q86584617-40BBE33F-DF3C-4137-A25F-AFE478240ABC @default.
- Q86584617 P2093 Q86584617-6428B8BF-46F2-4EEF-B181-95BACD292F12 @default.
- Q86584617 P2093 Q86584617-66864C04-C528-4A33-B820-A2CE79390299 @default.
- Q86584617 P2093 Q86584617-7A3EF7D5-C61B-4D7C-965D-251BF6050093 @default.
- Q86584617 P2093 Q86584617-7D181199-6538-4EBF-BDD6-F7282D4E05D7 @default.
- Q86584617 P2093 Q86584617-A369AC2A-B8C6-4435-8189-10C1B5A4457A @default.
- Q86584617 P2093 Q86584617-C5A69381-6527-4DC2-AEB3-3B9414CD67BF @default.
- Q86584617 P2093 Q86584617-D07BF041-1490-4D46-9CF4-7032B54AA153 @default.
- Q86584617 P304 Q86584617-60113A7B-360E-4FC6-9BB8-DCF20AAFCA55 @default.
- Q86584617 P31 Q86584617-A26F32CE-13F3-450F-A682-E8F3B6A2F13F @default.
- Q86584617 P356 Q86584617-E78A15C9-9838-47D5-B8AC-24CF2D19DFF1 @default.
- Q86584617 P433 Q86584617-6E80244D-4537-4E1E-981A-691E10A786C4 @default.
- Q86584617 P478 Q86584617-B55E1A78-3838-47C0-A5D1-B5DDE2F13B1C @default.
- Q86584617 P50 Q86584617-F9DDEB28-2DBE-4A05-8B1F-825345E87360 @default.
- Q86584617 P577 Q86584617-7841E9AB-2CB7-4B92-9A43-6B090C42747D @default.
- Q86584617 P698 Q86584617-B9EB860A-141B-48D1-87FE-FF0C1A3F9873 @default.
- Q86584617 P921 Q86584617-14D5A77D-D29D-4534-8230-F20294751750 @default.
- Q86584617 P921 Q86584617-7392D2A7-2DE3-4280-9BF0-2F77DE5CBA0F @default.
- Q86584617 P921 Q86584617-9EF53DE2-8CDD-47CF-A87C-50704B3F5FA6 @default.
- Q86584617 P921 Q86584617-CD7D27BD-A256-47E5-BF68-DAD8212BB263 @default.
- Q86584617 P356 DC14-1684 @default.
- Q86584617 P698 25614693 @default.
- Q86584617 P1433 Q5270111 @default.
- Q86584617 P1476 "Treatment with the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: a 52-week, randomized, double-blind clinical trial" @default.
- Q86584617 P2093 "Anthony H Barnett" @default.
- Q86584617 P2093 "Baptist Gallwitz" @default.
- Q86584617 P2093 "Hans-Juergen Woerle" @default.
- Q86584617 P2093 "Ilkka Tamminen" @default.
- Q86584617 P2093 "Julio Rosenstock" @default.